Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Brca1 and differentiation.

Marion Kubista1, Margit Rosner, Angelina Miloloza

  • 1AKH-EBO-E6 Division of Prenatal Diagnosis and Therapy, Obstetrics and Gynecology, University of Vienna, Währinger Gürtel 18-20, A-1090, Vienna, Austria.

Mutation Research
|December 5, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Comparative analysis of four PFAS regarding their toxicity to zebrafish development.

Ecotoxicology and environmental safety·2026
Same author

From stress to strength: mechanotransducing poly(aneu)ploidy into a community-level advantage in cancer.

Cancer metastasis reviews·2026
Same author

Cell-Penetrating Peptides and Supercharged Proteins: A Comprehensive Protocol from Isolation to Cellular Uptake.

Molecular pharmaceutics·2026
Same author

DUCKS4: a comprehensive workflow for Nanopore sequencing analysis of facioscapulohumeral muscular dystrophy (FSHD).

Human genomics·2026
Same author

The Role of Prostaglandins as Major Inflammatory Mediators in Colorectal Cancer.

International journal of molecular sciences·2025
Same author

mTORC2 inhibition reduces tumor burden via STAT1 activation and enhanced response to anti-PD-L1 therapy.

Cell death & disease·2025

Mutations in the breast cancer gene 1 (BRCA1) are linked to hereditary cancers. Understanding BRCA1

Area of Science:

  • Oncology
  • Genetics
  • Molecular Biology

Background:

  • Breast cancer is a prevalent malignancy in women.
  • Germline mutations in the human breast cancer gene 1 (BRCA1) are associated with hereditary breast and ovarian cancers.
  • Tumorigenesis in these individuals involves somatic inactivation of the remaining wild-type BRCA1 allele, supporting its role as a tumor suppressor.

Purpose of the Study:

  • To elucidate the mechanisms by which BRCA1 loss leads to tumorigenesis.
  • To understand the tissue-specific nature of BRCA1-associated cancers.
  • To investigate the role of Brca1 in normal cell differentiation processes.

Main Methods:

  • Analysis of BRCA1 expression patterns.
  • Functional studies of human BRCA1 and murine Brca1.

Related Experiment Videos

  • Investigation of Brca1's role in normal cell differentiation.

    • Main Results:

    • Current understanding of BRCA1 expression and function does not fully explain its specific association with breast and ovarian cancer development.
    • The mechanisms underlying BRCA1's tumor suppressor activity remain to be fully determined.
    • Further investigation into Brca1's role in differentiation is suggested.

    Conclusions:

    • The precise mechanisms linking BRCA1 loss to tumorigenesis require further elucidation.
    • Understanding the role of Brca1 in normal cell differentiation may explain the tissue-specific predisposition to breast and ovarian cancers.
    • Further research is needed to fully comprehend BRCA1's function in preventing these specific malignancies.